International Vaccine Institute and Bharat Biotech launch Phase II and III trials for chikungunya vaccine

sfg-2026
LATEST from ForumIAS
  1. 17 May | Exam Day Strategy for UPSC Prelims 2026 Click Here
  2. 17 May | ABC of Indian Sociology Series | 'H' = HAROLD COULD | Sociology Optional Simplified. Click Here to watch Smriti Mam explain the concept in simple terms →
  3. 15 May | If You Are Giving Prelims 2026, Watch This Before Entering the Exam Hall Click Here to listen to Ayush Sir's advice →

Source: Indian Express

What is the news?

A multi-country Phase II / III clinical trial of a vaccine led by the International Vaccine Institute (IVI) in partnership with Bharat Biotech International Ltd (BBIL) has begun in Costa Rica.

Read more: World may soon get a vaccine against Chikungunya

What is Chikungunya?

It is a viral disease transmitted to humans by infected mosquitoes

How is it transmitted?

Chikungunya virus is most often spread to people by Aedes aegypti and Aedes albopictus mosquitoes. These are the same mosquitoes that transmit the dengue virus.

Symptoms:

  • The most common symptoms of infection are fever and joint pain
  • Other symptoms may include headache, muscle pain, joint swelling, or rash.

Vaccination: Presently, there is no vaccine to prevent or medicine to treat Chikungunya virus infection.

Print Friendly and PDF
Blog
Academy
Community